Predictors of long-term mortality and re-ablation in patients undergoing ischaemic or non-ischaemic VT ablation

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Associate Professor Klaudia Vivien Nagy

Semmelweis University Heart and Vascular Center, Budapest (Hungary)

6 More presentations in this session

Presentation thumbnail

Outcomes of adults with Tetralogy of Fallot undergoing catheter ablation for atrial and ventricular arrhythmias

Doctor M. El-Harasis (Nashville, US)

Abstract Slides

Presentation thumbnail

Patterns of vegetative regulation in children with catecholaminergic polymorphic ventricular tachycardia after left cardiac sympathetic denervation

Ms R. Ildarova (Moscow, RU)

Presentation thumbnail

Stellate ganglion block in patients with ventricular arrhythmias, an innovative procedure that must be part of electrophysiologist therapeutic arsenal

Doctor A. Miranda-Arboleda (Boston, US)

Abstract Slides

Presentation thumbnail

Cryoablation of premature ventricular complexes arising from the septal region

Doctor G. Kolunin (Tyumen, RU)

Abstract Slides

Presentation thumbnail

Cardiac sympathetic denervation: evolving technique, expanding indications

Doctor V. Dusi (Turin, IT)

Abstract Slides

Access the full session

Session thumbnail

Ventricular arrhythmias and sudden cardiac death - treatment

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

Congress Presentation

Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?

Congress Presentation

Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources